|
gptkb:Bacillus_Calmette-Guérin_vaccine
|
variable, often 10-20 years
|
|
gptkb:Hammerite_Direct_to_Rust_Metal_Paint
|
up to 8 years
|
|
gptkb:European_Union_Registered_Community_Design
|
up to 25 years
|
|
gptkb:Bacillus_Calmette-Guérin
|
10–20 years
|
|
gptkb:Typbar-TCV
|
up to 5 years
|
|
gptkb:Ortho_Home_Defense
|
up to 12 months (indoor barrier)
|
|
gptkb:UK_registered_designs_system
|
up to 25 years
|
|
gptkb:Japanese_encephalitis_vaccination
|
1-2 years (inactivated)
|
|
gptkb:Abrysvo
|
at least one RSV season
|
|
gptkb:SPG_Act,_1988
|
5 years after demitting office (as per 2019 amendment)
|
|
gptkb:Unregistered_Community_Design
|
3 years
|
|
gptkb:United_States_Federal_Witness_Security_Program
|
as long as necessary
|
|
gptkb:Dukoral
|
up to 3 months for ETEC
|
|
gptkb:Rotarix
|
at least 3 years
|
|
gptkb:Witness_Security_Program
|
as long as necessary
|
|
gptkb:Vaxchora
|
at least 3 months
|
|
gptkb:Bacillus_Calmette–Guérin_vaccine
|
10 to 20 years
|
|
gptkb:Dukoral
|
up to 2 years for cholera
|
|
gptkb:Japanese_encephalitis_vaccination
|
longer (live attenuated)
|
|
gptkb:17D_vaccine
|
lifelong in most cases
|